Inspire Medical Systems, Inc. ( INSP ) Nowojorska Giełda Papierów Wartościowych

Cena: 131.55 ( 1.64% )

Aktualizacja 07-23 22:00
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Devices

Notowania:


Opis firmy:

Inspire Medical Systems, Inc., firma zajmująca się technologią medyczną, koncentruje się na rozwoju i komercjalizacji minimalnie inwazyjnych roztworów u pacjentów z obturacyjnym bezdechem sennym (OSA) w Stanach Zjednoczonych i na arenie międzynarodowej. Firma oferuje system Inspire, technologię neurostymulacji, która zapewnia bezpieczne i skuteczne leczenie umiarkowanego do ciężkiego OSA. Opracowuje także nowe, zamknięte rozwiązanie, które nieustannie monitoruje oddychanie pacjenta i zapewnia łagodną hipoglossalną stymulację nerwową w celu utrzymania otwartych dróg oddechowych. Firma została zarejestrowana w 2007 roku i ma siedzibę w Golden Valley w stanie Minnesota.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 1 011
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 97.7409
Ilość akcji: Brak danych
Debiut giełdowy: 2018-05-03
WWW: https://www.inspiresleep.com
CEO: Mr. Timothy P. Herbert
Adres: 5500 Wayzata Boulevard
Siedziba: 55416 Golden Valley
ISIN: US4577301090
Wskaźniki finansowe
Kapitalizacja (USD) 3 879 922 545
Aktywa: 796 194 000
Cena: 131.55
Wskaźnik Altman Z-Score: 36.1
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 60.1
Ilość akcji w obrocie: 98%
Średni wolumen: 560 390
Ilość akcji 29 493 900
Wskaźniki finansowe
Przychody TTM 755 594 000
Zobowiązania: 99 632 000
Przedział 52 tyg.: 123.0 - 225.0
Piotroski F-Score: 6
Umiarkowany (średnia jakość finansowa)
EPS: 2.2
P/E branży: 26.8
Beta: 1.358
Raport okresowy: 2025-08-04
WWW: https://www.inspiresleep.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Philip J. Ebeling Chief Operating Officer 675 410 1971
Mr. Richard J. Buchholz Chief Financial Officer 663 435 1968
Mr. Bryan K. Phillips Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary 639 900 1971
Mr. Randall A. Ban Chief Commercial Officer 624 446 1965
Mr. John C. Rondoni Chief Technology Officer 576 716 1980
Mr. Carlton W. Weatherby Chief Strategy Officer 553 292 1985
Dr. Charisse Y. Sparks FAAOS, M.D. Chief Medical Officer 31 348 1963
Mr. Timothy P. Herbert Founder, Chairman, Chief Executive Officer & President 1 357 920 1963
Ms. Melissa J. Mann Chief People Officer 0 0
Ms. Ezgi Yagci Vice President of Investor Relations 0 0
Lista ETF z ekspozycją na akcje Inspire Medical Systems, Inc.
Symbol ETF Ilość akcji Wartość
IJR 1 774 752 225 233 791
VB 748 537 103 447 813
VBK 411 751 56 903 988
IJT 261 570 33 195 891
SPSM 250 270 32 220 438
IWP 187 964 23 854 496
IHI 155 804 19 773 072
SLYG 145 631 18 700 707
SCHA 138 282 17 766 471
IWF 108 842 13 813 141
IWR 100 876 12 802 132
VIOO 100 347 13 867 955
VHT 93 059 12 860 753
SCHM 77 934 10 012 960
KOMP 71 965 9 113 547
DFAS 66 332 8 522 335
ISP6.L 43 190 5 481 213
IDP6.L 43 190 5 481 213
IUS3.DE 43 190 5 481 213
VIOG 38 061 6 062 356
VONG 36 158 4 997 035
ITOT 35 913 4 557 699
PSCH 29 643 3 808 532
XHE 22 918 3 011 039
IWB 21 634 2 745 617
WSML.L 20 722 2 629 857
IUSN.DE 20 722 2 629 857
WLDS.L 20 722 2 629 857
IYH 15 565 1 975 380
BBMC 13 765 1 786 284
FHLC 12 805 1 673 869
SMLF 11 456 1 453 879
IJR.AX 10 279 2 002 502
FLQM 9 225 1 222 866
DFAC 9 162 1 177 133
ESML 8 926 1 146 812
ISCG 8 117 1 030 152
CSUSS.MI 7 965 1 010 880
CUSS.L 7 965 1 010 880
CUS1.L 7 965 1 010 880
SXRG.DE 7 965 1 010 880
DFUS 7 912 1 016 533
RECS 7 896 1 014 478
IWV 7 752 983 771
6TVM.DE 7 121 957 418
LSPX.L 7 121 957 418
LYP2.DE 7 121 957 418
LSPU.L 7 121 957 418
ETFSP500.WA 7 121 957 418
SP5L.L 7 121 957 418
SP5H.PA 7 121 957 418
FMED 7 019 917 523
RWJ 6 942 891 908
PRFZ 6 682 858 503
SMMD 6 616 850 023
ESGV 6 322 1 006 968
SPTM 4 670 592 632
VONE 4 488 620 241
RZG 4 476 575 076
EQAL 4 353 559 273
UMDV.AS 4 146 526 125
DFAU 3 798 487 967
FNY 3 213 407 761
VFMO 2 948 469 557
FMDE 2 621 342 617
XJR 2 313 297 174
SCHK 2 282 296 135
VTHR 2 237 309 153
EZM 2 058 261 736
DFSU 1 520 195 289
DCOR 1 475 189 508
ISCB 1 399 177 559
SMMV 1 365 175 375
XEQT.TO 1 320 228 482
IYY 1 274 161 627
FDHT 1 234 161 308
XUU.TO 1 220 224 603
LSEQ 1 090 142 484
TILT 1 085 145 878
XSMC.TO 1 046 181 050
GUSA 998 128 223
XSMH.TO 993 171 922
XAW.TO 951 164 641
STXK 903 116 017
FAD 845 107 238
SPGM 718 91 239
SAA 535 68 736
V3AL.L 416 57 491
V3AA.L 416 57 491
R1GR.L 407 51 652
EKG 388 49 241
GGUS 364 46 766
HQGO 299 39 085
ESIX 229 29 412
XBAL.TO 203 37 425
XUH.TO 174 22 120
ANEW 140 17 987
ONEO 137 17 359
USFM.L 132 16 975
USUE.DE 132 16 975
CSA 132 19 629
VLU 85 10 825
BMED 54 6 809
STXG 52 6 680
CSF 41 6 097
MMTM 12 1 520
XTR.TO 7 963
PZW.TO 0 0
CLSE -1 643 -211 092
Wiadomości dla Inspire Medical Systems, Inc.
Tytuł Treść Źródło Aktualizacja Link
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine. globenewswire.com 2025-05-07 21:20:00 Czytaj oryginał (ang.)
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). zacks.com 2025-05-07 17:00:56 Czytaj oryginał (ang.)
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2025-05-07 15:00:56 Czytaj oryginał (ang.)
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results. zacks.com 2025-05-06 17:30:38 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Michael Sarcone - Jefferies Shagun Singh - RBC Chris Pasquale - Nephron Research Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Financial Group Jon Block - Stifel Brett Fishbin - KeyBanc Capital Markets Michael Polark - Wolfe Research Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPM Adam Maeder - Piper Sandler Richard Newitter - Truist Operator Good afternoon. My name is Dilem and I'll be your conference operator today. seekingalpha.com 2025-05-05 22:54:06 Czytaj oryginał (ang.)
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates Inspire Medical Systems (INSP) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to loss of $0.34 per share a year ago. zacks.com 2025-05-05 22:10:33 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter globenewswire.com 2025-05-05 20:02:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Inspire is scheduled to present at 2:20 p.m. globenewswire.com 2025-04-29 12:00:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D. MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively. globenewswire.com 2025-04-21 12:00:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025 MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. globenewswire.com 2025-04-01 12:00:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum MINNEAPOLIS, March 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 18, 2025. globenewswire.com 2025-03-06 10:00:00 Czytaj oryginał (ang.)
Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2025-02-25 12:50:45 Czytaj oryginał (ang.)
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire Medical”) on behalf of the company's long-term shareholders. globenewswire.com 2025-02-17 10:30:00 Czytaj oryginał (ang.)
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88% The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2025-02-13 12:56:12 Czytaj oryginał (ang.)
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter. zacks.com 2025-02-11 14:25:20 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today. seekingalpha.com 2025-02-11 01:55:01 Czytaj oryginał (ang.)
Inspire Medical's Earnings Surge in Q4 Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate. fool.com 2025-02-10 20:46:03 Czytaj oryginał (ang.)
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-10 20:31:07 Czytaj oryginał (ang.)
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago. zacks.com 2025-02-10 20:11:09 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 globenewswire.com 2025-02-10 18:02:00 Czytaj oryginał (ang.)
Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024. zacks.com 2025-02-05 12:21:35 Czytaj oryginał (ang.)
Inspire Medical Systems (INSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-02-03 13:00:32 Czytaj oryginał (ang.)
Why Investors Need to Take Advantage of These 2 Medical Stocks Now Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. zacks.com 2025-02-03 11:51:37 Czytaj oryginał (ang.)
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com 2025-01-21 11:56:09 Czytaj oryginał (ang.)
Inspire Medical Stock Falls Despite Solid Preliminary Q4 Revenues INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market penetration in existing centers and expansion into new implanting centers. zacks.com 2025-01-14 14:46:11 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2024 and Provides Initial 2025 Revenue Guidance Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024 Inspire Reports Year-over-Year Revenue Growth of 25% for the Fourth Quarter and 28% for the Full Year 2024 globenewswire.com 2025-01-13 08:45:00 Czytaj oryginał (ang.)
Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2025-01-07 13:06:24 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference MINNEAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. globenewswire.com 2024-12-30 10:00:00 Czytaj oryginał (ang.)
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound Shares of ResMed (RMD) and Inspire Medical Systems (INSP) fell Monday as the companies behind products to treat sleep apnea faced a new threat from weight-loss drugs. investopedia.com 2024-12-23 16:59:31 Czytaj oryginał (ang.)
Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors SAN MATEO, Calif.--(BUSINESS WIRE)-- #backpain--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE: INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions fo. businesswire.com 2024-12-05 14:12:00 Czytaj oryginał (ang.)
5 Growth Stocks to Buy in December for Impressive Short-Term Upside These five growth stocks have strong potential for December. These are: MNDY, PSN, PI, INSP, INGR. zacks.com 2024-12-04 11:01:34 Czytaj oryginał (ang.)
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025 Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV. zacks.com 2024-12-04 11:01:30 Czytaj oryginał (ang.)
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category. benzinga.com 2024-11-20 16:08:22 Czytaj oryginał (ang.)
UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. globenewswire.com 2024-11-15 10:00:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors. globenewswire.com 2024-11-11 08:45:00 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. globenewswire.com 2024-11-06 10:00:00 Czytaj oryginał (ang.)
INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the third quarter. zacks.com 2024-11-05 12:56:23 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – UBS Travis Steed – Bank of America Securities Adam Maeder – Piper Sandler David Rescott – Baird Michael Sarcone – Jefferies Richard Newitter – Truist Securities Larry Biegelsen – Wells Fargo Shagun Singh – RBC Kallum Titchmarsh – Morgan Stanley Jon Block – Stifel Anthony Petrone – Mizuho Americas Brett Fishbin – KeyBanc Capital Markets Chris Pasquale – Nephron Research Michael Polark – Wolfe Research Mike Kratky – Leerink Partners Suraj Kalia – Oppenheimer & Co Operator Good afternoon. My name is Dilem, and I'll be your conference operator today. seekingalpha.com 2024-11-04 23:12:31 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-11-04 21:36:21 Czytaj oryginał (ang.)
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Surpass Estimates Inspire Medical Systems (INSP) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.29 per share a year ago. zacks.com 2024-11-04 20:20:16 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. Announces Third Quarter 2024 Financial Results and Updates 2024 Outlook Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter Inspire Reports Year-over-Year Revenue Growth of 33% and Earnings per Share of $0.60 in the Third Quarter globenewswire.com 2024-11-04 18:02:00 Czytaj oryginał (ang.)
Seeking Clues to Inspire (INSP) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics Evaluate the expected performance of Inspire (INSP) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2024-10-30 12:20:39 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference MINNEAPOLIS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. globenewswire.com 2024-10-30 10:00:00 Czytaj oryginał (ang.)
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article. zacks.com 2024-10-29 07:05:21 Czytaj oryginał (ang.)
3 Medical Info Systems Stocks to Gain From Healthcare Digitization Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave. zacks.com 2024-10-28 15:26:08 Czytaj oryginał (ang.)
Inspire (INSP) Upgraded to Buy: What Does It Mean for the Stock? Inspire (INSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2024-10-18 17:00:33 Czytaj oryginał (ang.)
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 MINNEAPOLIS, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2024 after the close of trading on Monday, November 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. globenewswire.com 2024-10-07 12:00:00 Czytaj oryginał (ang.)